Free Submission Public Relations & NewsPR-inside.com
 
DeutschEnglish

Get the latest news
with our RSS feed
rss feed
Add to My Yahoo!
More information
Business

TomoTherapy to Present at Piper Jaffray Health Care Conference


Print article Print article
Refer this article Refer to a friend
© Business Wire 2008
2008-11-20 02:23:02 -

www.tomotherapy.com - cts.businesswire.com/ct/CT"id=smartlink&url=http%3A%2F%2Fwww .. announced today that Steve Hathaway, chief financial officer, and Del Coufal, vice president of marketing, will present at the Piper Jaffray 20th Annual Health Care Conference on Wednesday, December 3, 2008 at 12:00 p.m., ET. The conference is scheduled for December 2-3 at the New York Palace Hotel in New York City.
A

live Webcast of this presentation will be available on the cts.businesswire.com/ct/CT"id=smartlink&url=http%3A%2F%2Finv ... An archive of the Webcast will also be available on the company"s site for 30 days following the presentation.
About TomoTherapy Incorporated
TomoTherapy Incorporated has developed, manufactures and sells the TomoTherapy® Hi·Art® treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The Hi·Art treatment system combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company"s stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww ...
©2008 TomoTherapy Incorporated. All rights reserved. TomoTherapy, the TomoTherapy logo and Hi·Art are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated.


TomoTherapy Incorporated

Investor Contact:

Stephen C. Hathaway,

Chief Financial Officer

608.824.2800

mailto:shathaway@tomotherapy.com


Disclaimer: (c) 2009 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Terms & Conditions | Privacy | About us | Contact PR-inside.com